当地时间12月17日，美股三大指数集体收跌。道指跌0.47%；纳指下跌418.14点，跌幅1.81%；标普500 指数跌1.16%。 大型科技股普跌，特斯拉、博通跌超4%，谷歌跌超3%，Meta、苹果跌超1%。储能概念、半导体、计 算机硬件跌幅居前，康特科技跌超7%，超微电脑、阿斯麦、AMD、Arm跌超5%，科磊跌超4%。油 气、能源、贵金属板块走高，康菲石油涨超4%，埃克森美孚、英国石油涨超2%。 甲骨文跌超5%。甲骨文公司在该公司雄心勃勃的人工智能（AI）基础设施扩张计划上遭遇重大挫折， 其最大的数据中心合作伙伴Blue Owl Capital已决定不再支持一项价值100亿美元的数据中心项目。不 过，甲骨文随后回应称，该项目的谈判仍然按计划进行，整体推进情况符合预期，且交易中不包括蓝猫 头鹰资本。 2025年最大规模IPO：Medline Inc.(MDLN)美国IPO首日涨41.38%，报41美元，此前给出的IPO发行价为 29美元，融资62.6亿美元。 Medline负责制造和分销手套、手术袍及检查床等医疗物资，并已获得包括柏基投资和新加坡主权财富 基金在内的基石投资者的认购承诺。 纳斯达克中国金龙指 ...

每经编辑｜陈柯名 杜宇 Medline负责制造和分销手套、手术袍及检查床等医疗物资，并已获得包括柏基投资和新加坡主权财富基金在内的基石投资者的认购承诺。 | Medline | | | | --- | --- | --- | | MDLN us | | | | 41.250 昨收 29.000 量比 | 41.000 | | | 34.920 市值 539.17亿 换 | | | | 12.000 41.38% 开 35.000 市盈™ 42.59 额 | 29.29 Z | | | 异动解读: IPO上市+医疗耗材分销+自有品牌 ... ● × | | 122 103 | | -1.95% ⊙ 16:16 美东时间 -0.800 | 盘后 40.200 | | | 盘中 × 日K 周K 月K 五日 更多▼ | | | | 时间05:00 均价:36.913 最新41.000 涨幅+41.379% | | | | AW 卖价 | | 41.250 | | 买价 | | | | 04:59 40.900 86 | | -29-0.00 | | 04:59 40.540 1881 | | | | -- | | | ...

Core Viewpoint - Medline, a medical supplies manufacturer, is considering submitting its IPO application by the end of October, potentially becoming the largest IPO in the U.S. for the year if successful [1][2] Group 1: IPO Details - Medline aims to raise approximately $5 billion through the IPO, with backing from major investors including Blackstone, Carlyle Group, and Hellman & Friedman [1] - The company is headquartered in Northfield, Illinois, and had previously filed for an IPO in a "confidential" manner last December [1] - Goldman Sachs and Morgan Stanley are the lead underwriters for the IPO, with a potential valuation of up to $50 billion [1][2] Group 2: Market Context - The current U.S. stock market is near historical highs, with low volatility, and has raised $32 billion in IPOs this year, which is below the average for the same period before the pandemic [2] - If Medline successfully raises $5 billion, it would surpass the $1.75 billion raised by Venture Global in January, making it the largest IPO of the year [2] Group 3: Company Overview - Medline produces a range of medical supplies for hospitals and healthcare facilities, including gloves, surgical gowns, and examination tables, employing over 43,000 people globally [2] - The projected net sales for Medline in 2024 are approximately $25.5 billion [2] - The company was involved in a $34 billion leveraged buyout by private equity firms, which was one of the largest private equity transactions in history [2]

Core Insights - The medical bed industry in China is experiencing steady growth, with the market size reaching 15.184 billion yuan in 2023 and projected to grow to approximately 17.363 billion yuan in 2024, driven by an aging population and increasing demand for medical services [1][9]. Industry Definition and Classification - Medical beds, also known as healthcare beds, are specialized equipment designed for medical institutions, providing a safe and comfortable platform for patient diagnosis, treatment, care, and rehabilitation [1]. Industry Chain Analysis - The medical bed industry chain consists of four main segments: upstream raw materials and components supply, midstream manufacturing, downstream application services, and supporting industries. The upstream includes suppliers of metals, plastics, and electronic components, while midstream manufacturers produce various types of medical beds. Downstream applications cover hospitals, nursing homes, and home care, with a focus on after-sales services [3]. Development History - The Chinese medical bed industry has evolved over 40 years from reliance on imports to self-innovation. The industry has progressed through several phases: initial reliance on foreign technology, rapid domestic growth driven by healthcare reforms, and the current phase of high-quality development focusing on technology integration and green manufacturing [5]. Current Industry Status - The medical bed market in China is diverse, with ordinary beds holding a significant market share, while multifunctional and electric beds are growing rapidly. The increasing elderly population is expected to drive demand for specialized medical beds [9][12]. Downstream Application Analysis - Hospitals dominate the downstream application of medical beds, accounting for 68% of the market, followed by nursing homes at 18% and home care at 12%. Other institutions, such as rehabilitation centers, make up 2% [12]. Key Enterprises Analysis - The competitive landscape of the medical bed industry is diverse, with companies like Mindray focusing on high-end, intelligent medical beds, while others like Xinhua Medical offer a wide range of products. Companies such as Kofor Medical and Sykon Medical specialize in specific market segments, contributing to a complex competitive environment [14][18]. Future Development Trends - The future of the medical bed industry is expected to focus on high-end technology integration, lightweight materials, and multifunctional designs. High-end beds will incorporate smart sensors and AI for real-time monitoring, while lightweight designs will enhance mobility and comfort. Multifunctional beds will enable various clinical applications, improving efficiency and patient care [20][21][23].